BioCentury
ARTICLE | Clinical News

Bepreve regulatory update

June 29, 2009 7:00 AM UTC

FDA's Dermatologic and Ophthalmic Drugs Advisory Committee voted 7-0 on Friday to recommend approval of Ista's Bepreve bepotastine to treat ocular itching associated with allergic conjunctivitis. The ...